-
101.
公开(公告)号:US10808262B2
公开(公告)日:2020-10-20
申请号:US15039221
申请日:2014-11-25
Applicant: GENOMATICA, INC.
Inventor: Robin E. Osterhout , Anthony P. Burgard , Priti Pharkya , Stefan Andrae
IPC: C12N1/16 , C12N1/20 , C12P7/02 , C12P5/02 , C12P7/18 , C12N1/14 , C12P7/42 , C12P7/40 , C12N15/70 , C12N15/81 , C12P7/04 , C12P7/44 , C12P13/00 , C12P17/10
Abstract: The invention provides non-naturally occurring microbial organisms containing enzymatic pathways and/or metabolic modifications for enhancing carbon flux through acetyl-CoA. In some embodiments, the microbial organisms having such pathways also include pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation. The enhanced carbon flux through acetyl-CoA, in combination with pathways for generating reducing equivalents, formaldehyde fixation and/or formate assimilation can, in some embodiments, be used for production of a bioderived compound. Accordingly, in some embodiments, the microbial organisms of the invention can include a pathway capable of producing a bioderived compound of the invention. The invention still further provides a bioderived compound produced by a microbial organism of the invention, culture medium having the bioderived compound of the invention, compositions having the bioderived compound of the invention, a biobased product comprising the bioderived compound of the invention, and a process for producing a bioderived compound of the invention.
-
102.
公开(公告)号:US10793882B2
公开(公告)日:2020-10-06
申请号:US15383941
申请日:2016-12-19
Applicant: Genomatica, Inc.
Inventor: Robin E. Osterhout , Anthony P. Burgard , Priti Pharkya , Mark J. Burk
Abstract: The invention provides non-naturally occurring microbial organisms having a toluene, benzene, p-toluate, terephthalate, (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate, (2-hydroxy-4-oxobutoxy)phosphonate, benzoate, styrene, 2,4-pentadienoate, 3-butene-1ol or 1,3-butadiene pathway. The invention additionally provides methods of using such organisms to produce toluene, benzene, p-toluate, terephthalate, (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate, (2-hydroxy-4-oxobutoxy)phosphonate, benzoate, styrene, 2,4-pentadienoate, 3-butene-1ol or 1,3-butadiene.
-
公开(公告)号:US10787648B2
公开(公告)日:2020-09-29
申请号:US16063198
申请日:2016-12-13
Applicant: GENOMATICA, INC.
Inventor: Andreas Schirmer , Baolong Zhu , Emanuela Popova
Abstract: The disclosure relates to omega-hydroxylase-related fusion polypeptides that result in improved omega-hydroxylated fatty acid derivative production when expressed in recombinant host cells. The disclosure further relates to microorganisms for expressing the omega-hydroxylase-related fusion polypeptides for the production of omega-hydroxylated fatty acid derivatives.
-
公开(公告)号:US20200248189A1
公开(公告)日:2020-08-06
申请号:US16550010
申请日:2019-08-23
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Priti Pharkya , Robin E. Osterhout
IPC: C12N15/52 , C12P13/00 , C12P13/02 , C12P17/10 , C12P7/44 , C12N9/04 , C12N9/02 , C12N9/10 , C12N9/80 , C12N9/88 , C12P7/46 , C12P7/62
Abstract: The invention provides a non-naturally occurring microbial organism having an adipate, 6-aminocaproic acid or caprolactam pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective adipate, 6-aminocaproic acid or caprolactam pathway. The invention additionally provides a method for producing adipate, 6-aminocaproic acid or caprolactam. The method can include culturing an adipate, 6-aminocaproic acid or caprolactam producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding an adipate, 6-aminocaproic acid or caprolactam pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce adipate, 6-aminocaproic acid or caprolactam.
-
公开(公告)号:US20200040312A1
公开(公告)日:2020-02-06
申请号:US16499531
申请日:2018-03-29
Applicant: Genomatica, Inc.
Inventor: Kevin Hoff , Cara Ann Tracewell , Kui Chan , Amit Shah , Joseph Warner , Michael Noble
IPC: C12N9/02
Abstract: The invention provides polypeptides and encoding nucleic acids of aldehyde dehydrogenase variants. The invention also provides cells expressing aldehyde dehydrogenase variants. The invention further provides methods for producing 3-hydroxybutyraldehyde (3-HBal) and/or 1,3-butanediol (1,3-BDO), or an ester or amide thereof, comprising culturing cells expressing an aldehyde dehydrogenase variant or using lysates of such cells. The invention additional provides methods for producing 4-hydroxybutyraldehyde (4-HBal) and/or 1,4-butanediol (1,4-BDO), or an ester or amide thereof, comprising culturing cells expressing an aldehyde dehydrogenase variant or using lysates of such cells.
-
106.
公开(公告)号:US10513716B2
公开(公告)日:2019-12-24
申请号:US14053381
申请日:2013-10-14
Applicant: Genomatica, Inc.
Inventor: Robin E. Osterhout , Anthony P. Burgard
IPC: C12P7/64 , C12N9/12 , C12N9/04 , C12N9/02 , C12N9/10 , C07C31/20 , C12N9/16 , C12N9/88 , C12N9/00 , C12N15/52 , C12P7/04 , C12P7/24
Abstract: The invention provides non-naturally occurring microbial organisms containing a fatty alcohol, fatty aldehyde or fatty acid pathway, wherein the microbial organisms selectively produce a fatty alcohol, fatty aldehyde or fatty acid of a specified length. Also provided are non-naturally occurring microbial organisms having a fatty alcohol, fatty aldehyde or fatty acid pathway, wherein the microbial organisms further include an acetyl-CoA pathway. In some aspects, the microbial organisms of the invention have select gene disruptions or enzyme attenuations that increase production of fatty alcohols, fatty aldehydes or fatty acids. The invention additionally provides methods of using the above microbial organisms to produce a fatty alcohol, a fatty aldehyde or a fatty acid.
-
107.
公开(公告)号:US20190300918A1
公开(公告)日:2019-10-03
申请号:US15579118
申请日:2016-06-22
Applicant: Genomatica, Inc.
Inventor: Robin E. OSTERHOUT , Priti PHARKYA
IPC: C12P17/10 , C12N15/52 , C12P13/00 , C12P7/40 , C12P7/44 , C12P7/18 , C12N9/04 , C12N9/02 , C12P17/08 , C12N9/06 , C12N9/10 , C12N9/16 , C12N9/00
Abstract: Provided herein are non-naturally occurring microbial organisms having biosynthetic pathways for production of target products and one or more genetic modifications that reduce a byproduct of the biosynthetic pathway. Compositions of target products from such cells and methods of using such cells are provided.
-
108.
公开(公告)号:US20190276863A1
公开(公告)日:2019-09-12
申请号:US15971878
申请日:2018-05-04
Applicant: Genomatica, Inc.
Inventor: Jun Sun , Mark J. Burk , Anthony P. Burgard , Robin E. Osterhout , Wei Niu , John D. Trawick , Robert Haselbeck
Abstract: The invention provides non-naturally occurring microbial organisms comprising 1,4-butanediol (14-BDO) and gamma-butyrolactone (GBL) pathways comprising at least one exogenous nucleic acid encoding a 14-BDO and GBL pathway enzyme expressed in a sufficient amount to produce 14-BDO and GBL. The invention additionally provides methods of using such microbial organisms to produce 14-BDO and GBL.
-
公开(公告)号:US20190032096A1
公开(公告)日:2019-01-31
申请号:US15904198
申请日:2018-02-23
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Robin E. Osterhout , Stephen J. Van Dien , Cara Ann Tracewell , Priti Pharkya , Stefan Andrae
IPC: C12P7/46 , C12N9/04 , C12N15/81 , C08G63/00 , C12N15/74 , C12N9/06 , C12N9/10 , C07C59/235 , C12P7/24 , C12N15/77 , C12N15/70 , C07C55/10
Abstract: Provided herein is a non-naturally occurring microbial organism having a methanol metabolic pathway that can enhance the availability of reducing equivalents in the presence of methanol. Such reducing equivalents can be used to increase the product yield of organic compounds produced by the microbial organism, such as succinate. Also provided herein are methods for using such an organism to produce succinate.
-
公开(公告)号:US10167477B2
公开(公告)日:2019-01-01
申请号:US15914308
申请日:2018-03-07
Applicant: Genomatica, Inc.
Inventor: Priti Pharkya
Abstract: A non-naturally occurring microbial organism having an aniline pathway includes at least one exogenous nucleic acid encoding an aniline pathway enzyme expressed in a sufficient amount to produce aniline. The aniline pathway includes (1) an aminodeoxychorismate synthase, an aminodeoxychorismate lyase, and a 4-aminobenzoate carboxylyase or (2) an anthranilate synthase and an anthranilate decarboxylase. A method for producing aniline, includes culturing these non-naturally occurring microbial organisms under conditions and for a sufficient period of time to produce aniline.
-
-
-
-
-
-
-
-
-